This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.
这项发明涉及新颖的烷基酰胺衍
生物,作为布雷
金肽受体拮抗剂,用于治疗布雷
金肽调节的疾病,如疼痛、炎症、哮喘和过敏。此外,该发明涉及新颖的烷基酰胺衍
生物,作为布雷
金肽受体激动剂,用于治疗布雷
金肽调节的疾病,如高血压等。